Search Results - "Karlin, David Alan"

Phase 1b/2 study of pexidartinib (PEX) in combination with radiation therapy (XRT) and temozolomide (TMZ) in newly diagnosed glioblastoma by Colman, Howard, Raizer, Jeffrey J., Walbert, Tobias, Plotkin, Scott Randall, Chamberlain, Marc C., Wong, Eric T., Puduvalli, Vinay K., Reardon, David A., Iwamoto, Fabio Massaiti, Mrugala, Maciej M., Johnson, Brett, Sonty, Karthik, Karlin, David Alan, Pelayo, Michael, Hutchinson, Marguerite, Hsu, Henry

“…Abstract only…”
Get full text

Phase 1/2 precision medicine study of the next-generation BRAF inhibitor PLX8394 by Janku, Filip, Vaishampayan, Ulka N., Khemka, Vivek, Bhatty, Minny, Sherman, Eric Jeffrey, Tao, Jessica, Whisenant, Jonathan R., Hong, David S., Bui, Nam, Kummar, Shivaani, Feun, Lynn G., Parikh, Aparna Raj, Zhang, Chao, Michelson, Glenn, Martin, Eric, Shellooe, Rafe, Severson, Paul, Pelayo, Michael, Karlin, David Alan, Sharma, Sunil

“…Abstract only…”
Get full text

A phase 1b study to assess the safety of PLX3397, a CSF-1 receptor inhibitor, and paclitaxel in patients with advanced solid tumors by Sharma, Neelesh, Wesolowski, Robert, Reebel, Laura, Rodal, Mary Beth, Peck, Alexandra, West, Brian, Karlin, David Alan, Dowlati, Afshin, Le, Mai H., Coussens, Lisa M, Rugo, Hope S.

“…Abstract only…”
Get full text